Mc Anto Antony

Dr. Mc Anto Antony

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2023 in World Journal of Diabetes
Verified
Journal Article
Open access
MAMc Anto Antony
Mc Anto Antony
ACAniqa Chowdhury
Aniqa Chowdhury
DEDinesh Edem
Dinesh Edem
RRRishi Raj
Rishi Raj
PNPriyanshu Nain
Priyanshu Nain
RKRavi Kant
Ravi Kant
Diabetes mellitus is one of the most common causes of chronic kidney disease. Kidney involvement in patients with diabetes has a wide spectrum of clinical presentations ranging from asymptomatic to overt proteinuria and kidney failure. The development of kidney disease in diabetes is associated with structural changes in multiple kidney compartments, such as the vascular system and glomeruli. Glomerular alterations include thickening of the glomerular basement membrane, loss of podocytes, and segmental mesangiolysis, which may lead to microaneurysms and the development of pathognomonic Kimmelstiel-Wilson nodules. Beyond lesions directly related to diabetes, awareness of the possible coexistence of nondiabetic kidney disease in patients with diabetes is increasing. These nondiabetic lesions include focal segmental glomerulosclerosis, IgA nephropathy, and other primary or secondary renal disorders. Differential diagnosis of these conditions is crucial in guiding clinical management and therapeutic approaches. However, the relationship between diabetes and the kidney is bidirectional; thus, new-onset diabetes may also occur as a complication of the treatment in patients with renal diseases. Here, we review the complex and multifaceted correlation between diabetes and kidney diseases and discuss clinical presentation and course, differential diagnosis, and therapeutic oppor-tunities offered by novel drugs.

10 November 2021 in Cureus
Verified
Journal Article
Open access
AMAnu Alvin Mathew
Anu Alvin Mathew
RPRoshin Papaly
Roshin Papaly
AMAlvin Maliakal
Alvin Maliakal
LCLakshya Chandra
Lakshya Chandra
MAMc Anto Antony
Mc Anto Antony
Subacute thyroiditis can be rarely associated with autoimmune thyroid disorders. It includes Graves' disease which is characterized by the presence of a highly specific antibody known as thyroid-stimulating hormone (TSH) receptor antibody (TRAb). There are three types of TRAb: TSH receptor stimulating antibody (TSAb) which stimulates the TSH receptor causing Graves' disease, TSH receptor blocking antibody (TBAb) which blocks the TSH receptor causing hypothyroidism, and a neutralizing antibody which does not alter the thyroid function. There are two assays used to check the TRAb: the thyroid-stimulating immunoglobulin (TSI) assay and the TSH receptor-binding inhibitor immunoglobulin (TBII) assay out of which the TSI assay measures the stimulating antibody which is specific for graves' disease. Although autoimmune thyroid disorders can rarely occur following subacute thyroiditis, their clinical presentation is usually compatible with the type of antibody detected in the patient’s serum. We present a unique case of a 44-year-old patient who presented with subacute thyroiditis followed by the development of persistent hypothyroidism even in the presence of elevated Graves' disease-specific TSI and TRAb.

13 October 2023 in Cureus
Verified
Journal Article
Open access
PDF file
MAMc Anto Antony
Mc Anto Antony
SPSiddharth Patel
Siddharth Patel
VVVipin Verma
Vipin Verma
RKRavi Kant
Ravi Kant
COVID-19, which is caused by the RNA virus, SARS-CoV-2, mainly affects the respiratory system and has a varied clinical presentation. However, several studies have shown that COVID-19 can also affect the gastrointestinal (GI) system. Patients can experience various GI symptoms, such as vomiting and diarrhea, and the virus has been detected in the stool samples of patients hospitalized with COVID-19. There have also been rare reports of COVID-19 presenting with isolated GI symptoms and lack of respiratory symptoms, and the virus has also been detected for prolonged periods in the fecal samples of COVID-19 patients. Major alterations in the gut microbiome in the form of depletion of beneficial organisms and an abundance of pathogenic organisms have been reported in the fecal samples of hospitalized COVID-19 patients. Although the US FDA has approved several drugs to manage COVID-19, their efficacy remains modest. So, there is a constant ongoing effort to investigate novel treatment options for COVID-19. Health supplements like probiotics, prebiotics, postbiotics, and synbiotics have been popularly known for their various health benefits. In this review, we have summarized the current literature, which shows the potential benefit of these health supplements to mitigate and/or prevent the clinical presentation of COVID-19.

26 February 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SPSiddharth Mbbs Patel
Siddharth Mbbs Patel
ARAmogh Reddy
Amogh Reddy
MAMc Anto Antony
Mc Anto Antony
MTMrudula Thiriveedi
Mrudula Thiriveedi
PPPrutha Mbbs Pathak
Prutha Mbbs Pathak
HRHinal Do Rathi
Hinal Do Rathi
Diabetes mellitus is a chronic medical condition which affects millions of adults worldwide. It can result in various complications and is associated with a higher rate of hospitalizations. Blood glucose management in hospitalized patients is a critical aspect of care, which is important for preventing complications, improving patient outcomes, and reducing the length of hospital stay. Blood glucose control is difficult to achieve secondary to multiple factors involved in its regulation (e.g. type of medical illness, corticosteroid use, and enteral feeding) as well as varying evidence to determine different aspects of it. Our goal is to summarize the existing evidence from observational studies, clinical trials, and various society guidelines on blood glucose management in the hospitalized setting. Export

26 May 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SPSiddharth Mbbs Patel
Siddharth Mbbs Patel
TFTaylor Faust
Taylor Faust
ACAnil Chimakurthy
Anil Chimakurthy
PPPrutha Pathak
Prutha Pathak
MAMc Anto Antony
Mc Anto Antony
SBSujatha Baddam
Sujatha Baddam
Introduction and Importance: Vitamin B6 (pyridoxine) deficiency is a rare but reversible cause of seizures in adults, which is often overlooked in post gastrectomy patients. This case highlights the critical role of nutritional supplementation in preventing severe complications such as neuropsychiatric manifestations and seizures, emphasizing the importance of vigilance in postoperative care and patient follow-up. Case presentation: A 46-year-old woman with a history of partial gastrectomy presented with intermittent confusion and somnolence for a duration of 6 months. Physical exam revealed temporal wasting, dry skin, and a low BMI. Laboratory tests showed undetectable levels of vitamin B6, while an electroencephalogram (EEG) demonstrated electrographic status epilepticus. Despite antiepileptic therapy the patient’s symptoms continued until high dose intravenous vitamin B6 was administered, leading to rapid improvement clinically and on EEG. The patient was discharged on oral pyridoxine and multivitamins, remaining seizure-free including at her 6-month follow-up Clinical discussion: This case illustrates the rare occurrence of adult-onset seizures due to vitamin B6 deficiency, following gastric surgery. A thorough literature review shows a link between pyridoxine deficiency and seizures, specifically in the context of malnutrition or chronic health conditions. This case underscores a need for routine preoperative and postoperative nutritional assessments, including micronutrient level monitoring in order to mitigate these risks. Conclusion: This case illustrates an extremely rare but preventable clinical syndrome of vitamin B6 deficiency and re-emphasizes the role of nutritional supplementation after gastrectomy. Prompt recognition and treatment of this condition are essential, highlighting the critical role of comprehensive nutritional care and postoperative management of gastrectomy patients.